Today’s FN Arena (but, by reputation, is not UBS -who is recommending it -likely to have loaned it’s shares for short selling at the same time?)
https://www.fnarena.com/index.php/2019/03/05/ama-group-zooms-in-on-acquisitions/
AMA Group Zooms In On Acquisitions
Small Caps | 10:00 AM
AMA Group has substantial opportunities in the automotive aftermarket and continues to consolidate a position in panel repair.
-Targeting $1bn in revenue by FY21
-Enters heavy-motor panel repair market, procurement negotiations continue
-Sustained organic revenue growth and acquisition opportunities support outlook
By Eva Brocklehurst
Automotive aftermarket specialist AMA Group ((AMA)) continues to grow and consolidate its position in panel repair and vehicle protection. The company has cited an underperforming acquisition, ARM in Sydney, as the cause of weak margins in panel repair in the first half result.
Panel repair operating earnings (EBITDA) margins were reduced to to 8.8% versus 11.5% in the prior corresponding half. AMA Group has reaffirmed its FY19 guidance for operating earnings, excluding greenfield losses, of $58-60m and a target of $1bn in revenue by FY21.
The company has entered the heavy-motor panel repair market, while procurement negotiations continue. A major customer is expected before the full-year results in August.
Brokers, while disappointed with the miss to expectations in the first half, have zoomed in on the consolidation opportunities, which UBS calculates is now worth over $70m in revenue. This will be complemented by 4-6 greenfield developments in the pipeline. UBS does not consider the valuation demanding and maintains a Buy rating with a $1.35 target.
Wilsons is still slightly concerned about panel margins, although agrees that sustained revenue growth in panels and the acquisition pipeline support the company's consolidation strategy and outlook. Operating cash flow benefited from a negative working capital position while gearing remains modest. An interim dividend of 0.5c per share was in line with the prior corresponding period but below the broker's forecasts.
Wilsons lowers its forecasts to the lower end of guidance, which marks a -5% decline in estimates for earnings per share. The broker also lowers the longer-term panel margin forecasts to 9.7% from 10% and maintains a Hold rating and $1 target.
At this stage, neither Wilsons nor Bell Potter include any contribution from the new procurement business in estimates because of a lack of clarity. Earnings were slightly lower than Bell Potter's estimates for the first half while revenue was modestly ahead, growing 32% to $302.4m.
The full story is for FNArena subscribers only. To read the full story plus enjoy a free two-week trial to our service SIGN UP HERE
If you already had your free trial, why not join as a paying subscriber? CLICK HERE
- Forums
- ASX - By Stock
- Short Selling Now Going On
Today’s FN Arena (but, by reputation, is not UBS -who is...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AMA (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $286.9M |
Open | High | Low | Value | Volume |
6.4¢ | 6.6¢ | 6.4¢ | $274 | 4.228K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 53226 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 300441 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 59761 | 1.050 |
3 | 2596 | 1.045 |
3 | 3726 | 1.040 |
2 | 2898 | 1.035 |
1 | 50000 | 1.030 |
Price($) | Vol. | No. |
---|---|---|
1.055 | 77023 | 3 |
1.060 | 53603 | 4 |
1.065 | 51503 | 3 |
1.070 | 2503 | 1 |
1.080 | 1158 | 1 |
Last trade - 10.01am 25/11/2024 (20 minute delay) ? |
Featured News
AMA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online